Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials

By sjmartinez • June 27, 2024

Huang C, Li L, Liu W, Fang Y, Jiang S, Li Y, Fonarow GC, Sia CH, Yeo LLL, Tan BYQ, Lip GYH, Yang Q, Zhou X. Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Heart Rhythm. 2024 Jun 24:S1547-5271(24)02812-1. doi: 10.1016/j.hrthm.2024.06.038. Epub ahead of print. PMID: 38925332.

Tags: AHREs, Cardiology/Epi, DOACs, Publications, Time to benefit, time to harm

A rare case of May-Thurner syndrome due to external compression of the right and left common iliac veins

Schwarzman L, Aguilar J, Megowan N. A rare case of May-Thurner syndrome due to external compression of the right and left common iliac veins. J[...]

Clinical Characteristics and Current Management of U.S. Adults at Elevated Risk for Heart Failure Using the PREVENT Equations: A Cross-Sectional Analysis

Sussman JB, Wilson LM, Burke JF, Ziaeian B, Anderson TS. Clinical Characteristics and Current Management of U.S. Adults at Elevated Risk for Heart Failure Using[...]

Assessment of cardiovascular diagnoses associated with telemedicine during and after the COVID-19 pandemic

Shan R, Patel N, Chen JY, Cho D. Assessment of cardiovascular diagnoses associated with telemedicine during and after the COVID-19 pandemic. J Telemed Telecare. 2024[...]